Codexis, Inc.

Day range

$1.28 – $1.30

Open

$1.30

Prev close

$1.28

Volume

392.38K

Market cap

$140.17M

Shares out

109.51M

P/E

—

P/S

1.80

P/B

4.25

P/FCF

—

ROE

-93.2%

ROA

-25.6%

Debt/Equity

1.24

Div yield

0.00%

As of Oct 23, 2026

• Public offeringJul 27, 2026

  On July 23, 2026, Codexis, Inc. (the "Company") entered into an underwriting agreement with Piper Sandler & Co. and Cantor Fitzgerald & Co., as representatives of the several underwriters named therein, pursuant to which the Company agreed to issue and sell 16,666,667 shares of its common stock to the Underwriters. The Shares were sold at a public offering price of $1.50 per Share.

• Preliminary resultsJul 23, 2026

  On July 23, 2026, Codexis, Inc. (the "Company") disclosed that it expects to report total revenue for the three months ended June 30, 2026 to be at least $14.8 million, and cash, cash equivalents and short-term investments as of June 30, 2026 of approximately $54.9 million. These amounts are preliminary and subject to completion of the Company's financial closing procedures.

• Director departureApr 14, 2026

  On April 8, 2026, Dennis Wolf notified the Board of Directors (the "Board") of Codexis, Inc. (the "Company") of his decision to resign from the Board, effective immediately. In connection with his resignation from the Board, Mr. Wolf also resigned from his positions as a member of the Audit Committee and the Compensation Committee of the Board, effective immediately.

• Workforce reductionNov 6, 2025

  On November 6, 2025, in alignment with its enhanced strategic focus, the Company publicly announced that it is implementing a workforce reduction of approximately 24%. The Company expects that the payment of post-employment benefits to impacted employees, as well as the payment of other expenses such as related tax costs, will result in the recognition of an additional expense of approximately $3.5 million.

• Equity compensation grantJun 11, 2025

  The Company's stockholders approved an amendment to the Company's 2019 Incentive Award Plan, as amended (the "Amended 2019 Plan") to add an additional 8,000,000 shares to the number of shares of Common Stock authorized for issuance under the Amended 2019 Plan.

Days to cover

5.0

Short interest

4.84M

Avg volume

967.63K

As of Sep 30, 2026 · reported to FINRA twice monthly.

• Codexis Announces Pricing of Public Offering of Common Stock
  neutralGlobeNewswire Inc.· Jul 23, 2026
• Codexis to Participate in Cantor Global Healthcare Conference
  positiveGlobeNewswire Inc.· Aug 28, 2025
• Codexis’ Landmark Presentations at TIDES USA Highlight Reproducibility and Process Simplification of the ECO Synthesis Platform for Manufacturing siRNA
  positiveGlobeNewswire Inc.· May 22, 2025
• Codexis Announces Byron Dorgan to Retire from Board of Directors
  positiveGlobeNewswire Inc.· Apr 9, 2025
• Specialty Enzymes Market to Expand at 7.5% CAGR, Reaching USD 10.7 Billion by 2032 | SNS Insider
  positiveGlobeNewswire Inc.· Feb 20, 2025